Skip to content

Pacing Strategy Affects the Sub-Elite Marathoner's Cardiac Drift and Performance.

PMID 32140116 (2019): pacing — Time-trial performance (study note for endurance athletes).

Last updated/Feb 23, 2026, 11:13 PM

Study note • PMID 32140116

Pacing Strategy Affects the Sub-Elite Marathoner's Cardiac Drift and Performance.

Frontiers in psychology2019 • DOI 10.3389/fpsyg.2019.03026
Evidence C60/100
Action 2: Consider

Worth trying if it fits your goal and context.

ELI5

In plain language

The question of cardiac strain arises when considering the emerging class of recreational runners whose running strategy could be a non-optimal running pace. (controlled study; n=140 runners).

Results section: no clear change in Time-trial performance under the tested conditions. Treat this as a signal, not a guarantee; confirm methods and context in the full paper.

Takeaways

What the abstract suggests

  • Study question: The question of cardiac strain arises when considering the emerging class of recreational runners whose running strategy could be a non-optimal running pace.
  • Results section: no clear change in Time-trial performance under the tested conditions.
  • Population: n=140 runners.
  • Protocol cues: abstract may omit dose/timing; use the full paper to replicate accurately.

Protocol

Protocol (as reported)

  • Intervention/exposure: pacing.
  • Dose/time/duration: abstract doesn’t include enough detail; use the full paper’s methods section.
  • Outcomes: Time-trial performance.
  • Replication note: abstracts often omit adherence and timing; confirm details before changing training or supplementation.

Fit

Who it helps, and who should skip it

Who it helps

  • Athletes similar to the study population (n=140 runners) working on pacing.
  • Athletes who can measure Time-trial performance with a repeatable workout or time-trial effort.

Who should skip

  • If you have symptoms or conditions that make the intervention risky, get professional guidance.
  • If you’re near race day and can’t safely test, defer the experiment.

Methods

What the study actually did

  • Design: controlled study.
  • Population: n=140 runners.
  • Outcomes measured: Time-trial performance.
  • Source: PubMed PMID 32140116 (2019) — Frontiers in psychology.

Full paper

What the full paper adds

  • Participants (paper): n=140 runners.
  • Results section: no clear change in Time-trial performance under the tested conditions.

Results excerpt

What the abstract reports

We therefore named this group of runners the "fallers." Furthermore, the fallers had significantly lower performance (p = 0.006) and higher cardiac drift (p < 0.0001) than the non-fallers.

Note: excerpts are short; for full context, read the paper.

Limits

Limitations & bias

  • Abstract-only summaries can miss critical details (population, protocol, adherence, and context).
  • Single studies often don’t generalize to your event, history, and training load; treat results as a starting point.
  • If your context differs (elite vs recreational; cycling vs running), adjust expectations and be conservative.
  • This is performance information, not medical advice.

Coaching beta

Get a plan that adapts to your life.

Join the 26weeks.ai TestFlight beta for adaptive coaching, recovery-aware adjustments, and race-week reminders.

Keep going

Sources